Browsing Over 783 Presentations

Sort By
Artificial intelligence (AI) (ID 96) Special Session

The role of radiomics (ID 1285)

Lecture Time
17:31 - 17:50
Speakers
  • Alberto S. Tagliafico (Genova, Italy)
Session Name
Artificial intelligence (AI) (ID 96)
Location
Channel 5, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
17:10 - 18:10
Artificial intelligence (AI) (ID 96) Special Session

The role of AI in oncology drug development (ID 1286)

Lecture Time
17:50 - 18:09
Speakers
  • Sriganesh Srihari (Brisbane, Australia)
Session Name
Artificial intelligence (AI) (ID 96)
Location
Channel 5, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
17:10 - 18:10
Artificial intelligence (AI) (ID 96) Special Session

Closing remarks and conclusions (ID 1288)

Lecture Time
18:09 - 18:10
Speakers
  • Fatima Cardoso (Lisbon, Portugal)
Session Name
Artificial intelligence (AI) (ID 96)
Location
Channel 5, Virtual Meeting, Virtual Meeting, Singapore
Date
22.11.2020
Time
17:10 - 18:10

Clinical experience in unresectable HCC (ID 1304)

Live Q&A (ID 1305)

Welcome and introduction (ID 1300)

Immune checkpoint molecules: key players in the pathogenesis of HCC (ID 1301)

Optimising the immune response: exploring high-dose priming with anti-CTLA-4 therapy in unresectable HCC (ID 1302)

Recent advances in the treatment of unresectable HCC (ID 1303)

Welcome and introduction (ID 1294)

Emerging immuno-oncology treatment strategies for first-line ES-SCLC (ID 1295)

Treating ES-SCLC using immuno-oncology: A clinical case study (ID 1296)